Medpace Inc.

347.08
3.70 (1.08%)
At close: Feb 04, 2025, 3:59 PM
346.98
-0.03%
After-hours Feb 04, 2025, 04:00 PM EST
undefined%
Bid 319.95
Market Cap 10.79B
Revenue (ttm) -
Net Income (ttm) -
EPS (ttm) 11.42
PE Ratio (ttm) 30.39
Forward PE n/a
Analyst Hold
Ask 364.52
Volume 179,425
Avg. Volume (20D) 278,905
Open 342.52
Previous Close 343.38
Day's Range 342.52 - 351.45
52-Week Range 293.37 - 459.77
Beta undefined

About MEDP

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory...

Sector Healthcare
IPO Date Aug 11, 2016
Employees 5,900
Stock Exchange NASDAQ
Ticker Symbol MEDP

Analyst Forecast

According to 9 analyst ratings, the average rating for MEDP stock is "Hold." The 12-month stock price forecast is $367, which is an increase of 5.74% from the latest price.

Buy 44.44%
Hold 55.56%
Sell 0.00%
Stock Forecasts

Next Earnings Release

Medpace Inc. is scheduled to release its earnings on Feb 10, 2025, after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
-7.47%
Medpace Holdings shares are trading lower after th... Unlock content with Pro Subscription
3 months ago
-0.98%
Medpace Holdings shares are trading lower after the company reported worse-than-expected Q3 sales results.